Lv12
20 积分 2025-02-16 加入
MAPK inhibition in BRAFV600E CRC
10小时前
已完结
MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancer
12小时前
已完结
Functional characterization of a PROTAC directed against BRAF mutant V600E
13小时前
已完结
Encorafenib: A Review in Metastatic Colorectal Cancer with a BRAF V600E Mutation
19小时前
已完结
The role of T-LAK cell-originated protein kinase in targeted cancer therapy
7天前
已完结
Novel raf kinase protein–protein interactions found by an exhaustive yeast two-hybrid analysis
7天前
已完结
Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations
8天前
已完结
Negative regulation of RAF kinase activity by ATP is overcome by 14-3-3-induced dimerization
12天前
已完结
The Discovery of Exarafenib (KIN-2787): Overcoming the Challenges of Pan-RAF Kinase Inhibition
22天前
已完结
RAF kinase dimerization: implications for drug discovery and clinical outcomes
22天前
已完结
皖公网安备34019202002308
